Back to search

United Kingdom· GB-APID-5356011000001108

Phenoxybenzamine 100mg/2ml concentrate for solution for infusion ampoules

A phenoxybenzamine product containing phenoxybenzamine, registered in United Kingdom by Mercury Pharma Group Ltd. The same ATC class is registered in 4 of our 19 countries.

ATC C04AX02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedPhenoxybenzamine 100mg/2ml concentrat…ATCC04AX02REGISTER NO.GB-APID-5356011000001…PACKS LISTED0CHECKEDOctober 2, 2026

Where it is registered

Phenoxybenzamine is registered in 4 of 19 countries.

Countries holding a registration under ATC C04AX02 (phenoxybenzamine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 2 of them publish a price we can compare per daily dose

Phenoxybenzamine · ATC C04AX02

4 / 19 countries

  • Germany
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Phenoxybenzamine
Manufacturer
Mercury Pharma Group Ltd
Country
United Kingdom (GB)
ATC code
C04AX02
ATC class
Phenoxybenzamine
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
October 2, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

43 interactions on record for phenoxybenzamine.

Graded by severity as the source publishes them — 43 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Phenoxybenzamine · interactions on record

43 records

  • 43 moderate

Most severe, free to view

  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Phenoxybenzamine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phenoxybenzamine products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Dibenzyran 10

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e110b59c-8bbe-4105-b76c-40aa417dfc42
GET /v1/drugs/e110b59c-8bbe-4105-b76c-40aa417dfc42?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "5356011000001108",
  "desc": "Phenoxybenzamine 100mg/2ml concentrate for solution for infusion ampoules (Mercury Pharma Group Ltd)",
  "form": "Solution for infusion",
  "vpid": "36015311000001107",
  "source": "dmd",
  "vtm_id": "777173002",
  "strength": "50 mg",
  "substance": "Phenoxybenzamine",
  "ingredient": "Phenoxybenzamine hydrochloride",
  "supplier_code": "151601000001102"
}

See everything about phenoxybenzamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.